The same molecules significantly decreased after treatment with DNase I and were reduced in TLR-9 deficient cells, with a concomitant decrease in tumor cells migration and invasion, suggesting TLR-9 as a possible therapeutic target in preventing recurrences [138]. The gene discussed is TLR9; the disease is neoplasm.